NIEUW: recomDot Borrelia IgG, IgM - ImmunoBlot in 96well ELISA plaat format

Intro tekst

Mikrogen kondigt de eerste test van de nieuwe Mikrogen productlijn recomDot aan. De nieuwe eiwitmicroarray-technologie combineert de hoge informatieve waarde van immunoblot-assays met eenvoudige, geautomatiseerde verwerking op standaard ELISA-instrumenten. Het testsysteem is perfect voor grotere volumes en vereiste snelle doorlooptijden.

Afbeelding

Introduction of a novel easy-to-use microarray for Borrelia diagnostics
Julia Schamberger, Stefan Ammer, Michael Mayer, Torsten Pirch, Angela Eser, Ingrid Albrecht-Walz, Friedhelm Struck, Karin Wochinz-Richter, Kerstin Wagner, Oliver Böcher, Erwin Soutschek

Mikrogen GmbH, Neuried, Germany

The new recomDot Borrelia is based on recombinant, highly specific, immunodominant and phase-specific antigens of the five human-pathogenic Borrelia species. Tentative diagnoses and suspected disease stages of patient samples found borderline or positive in screening can be substantiated by means of typical IgG and IgM antibody constellations.

The recomDot Borrelia protein microarray combines the high informative value of the Line immunoassay with easy, automated processing on standard ELISA instruments.

Results Dot.JPGConclusion

• The recomDot Borrelia is highly sensitive and specific for the detection of antibodies against Borrelia burgdorferi ssp. Cross-reactivity turned out to be very low, accuracy of the recomDot has been shown to be excellent.
• The recomDot Borrelia is a fast, easy-to-use and a more economical alternative to conventional methods confirming screening results.

Download hier de poster